# Unusual Presentation of a Hepatic Neuroendocrine Tumor With Elevated CEA and CA 19–9: A Case Report

**Authors:** Eli Zolotov, Anat Sigal, Sara Hazaveh, Vanisha Patel, Hongfa Zhu

PMC · DOI: 10.7759/cureus.52858 · Cureus · 2024-01-24

## TL;DR

This case report describes a rare liver tumor that presented with elevated tumor markers and mimicked cirrhosis, highlighting the diagnostic value of CEA and CA 19-9 in unusual neuroendocrine tumors.

## Contribution

First reported case of a liver neuroendocrine tumor with elevated CEA and CA 19-9 and no biliary or bowel abnormalities.

## Key findings

- Elevated CEA and CA 19-9 levels were observed in a patient with a liver neuroendocrine tumor.
- MRI and CTA showed no abnormalities in the gallbladder, biliary tree, or bowel.
- Liver biopsy confirmed a high-grade neuroendocrine carcinoma with reactive fibrosis.

## Abstract

Neuroendocrine tumors (NETs) of the gastrointestinal tract (GIT) are rare malignancies, which may have unique presentations. The diagnostic process predominantly relies on immunohistochemical analysis. While tumor markers are extensively utilized in diagnosing and monitoring GI malignancies, their specific role in NETs has not been fully explored.

This case describes an 83-year-old male presenting with jaundice and general weakness. Diagnostic imaging through MRI and CT angiography (CTA) revealed a nodular texture on the liver's surface suggesting cirrhosis. The presence of elevated tumor markers, specifically carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA 19-9), raised suspicions of malignancy. A subsequent liver biopsy confirmed the diagnosis of small-cell high-grade neuroendocrine carcinoma accompanied by reactive fibrosis.

As per our knowledge, this case is the first recorded instance of a liver neuroendocrine tumor (NET) exhibiting elevated levels of both CEA and CA 19-9, with no abnormalities detected in the gallbladder, biliary tree, and bowel in the MRI with magnetic resonance cholangiopancreatography (MRCP) and CTA. This is an atypical presentation of a liver NET, mimicking cirrhotic liver morphology, and underscores the potential diagnostic relevance of tumor markers CEA and CA 19-9 in such cases.

## Linked entities

- **Proteins:** CEACAM5 (CEA cell adhesion molecule 5)
- **Diseases:** cirrhosis (MONDO:0005155)

## Full-text entities

- **Genes:** CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}
- **Diseases:** neuroendocrine carcinoma (MESH:D018278), Hepatic Neuroendocrine Tumor (MESH:D018358), jaundice (MESH:D007565), GIT (MESH:D005770), cirrhotic liver (MESH:D008103), weakness (MESH:D018908), GI malignancies (MESH:D009369), cirrhosis (MESH:D005355)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10885841/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10885841/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC10885841/full.md

---
Source: https://tomesphere.com/paper/PMC10885841